A companion diagnostic is a predictive biomarker test, utilized to support dosing decision-making for patient stratification and treatment. It received global support and the market size is expected to double within the next 5 years. This webinar reviews the importance and regulatory success of companion diagnostic biomarker assays in currently approved drugs, as well as forecasting the trend and possible issues that might arise in the future. In addition, the outsourcing of companion diagnostic tests to a contract research lab will be discussed.
Register to gain access to gated resources.
Thank you for registering!
You may now view the resource below.
In this infographic, we report on key future trends in precision medicine and companion diagnostics, challenges currently faced, and the common technologies used.
In this panel discussion, expert panelists, including Dr. Kai Wang, discuss the current state of precision medicine and companion diagnostics research. They provide insights into how they approach drug development research with a personalized approach and the role of companion diagnostics in this development. Panelists also review the state of current regulations regarding companion diagnostics in relation to laboratory-developed tests.